Initially, she emphasized on increasing the awareness of HPV among women in order to make sure of successful vaccination. According to a recent study, it was revealed that educational efforts should be concentrated on increasing womens knowledge and awareness of HPV while expecting the availability of HPV vaccines and HPV tests for screening (Hanisch et al., 2007).
Therefore, I would encourage women through proper education that might facilitate them to choose HPV vaccination at the earliest stage of infection. I would primarily focus on women living in low socioeconomic conditions and conduct questionnaires. The information thus obtained would be conveyed to health care professionals and appropriate education programs would be undertaken.
She also says that there is a need of a medical screening method known as Pap test in addition to HPV vaccinations. Because, Pap tests have proven to be essential to detect cervical cancers and precancerous changes, even in women who have been vaccinated against HPVs according to National Cancer Institute.
So, I would implement screening programs targeted for HPV vaccinations by also including Pap test i
n order to ensure smooth detection of HPV infections. However, Ms.Debby has mentioned that age factor should be given prior importance while approaching any method of vaccination strategies. It was reported that vaccinating girls and women older than 2 years of age may accelerate the reduction in cervical cancer rates and there is a necessity of continued cervical cancer screening regardless of vaccination (Harper & Paavonen, 2008).
Therefore, I would concentrate on women of younger age in screening programs by approaching schools and other important locations where we could gather information about these populations with reference to HPV infection. Further, Ms.Debby has informed that there is a need to carry out large follow -up studies in order to make sure of the vaccine effectiveness. Stanley and Villa (2008) recently described that vaccinated populations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy. This is because effective monitoring would benefit from linkage of vaccination history and screening history, as well as specific measurement of HPV exposure, both DNA and serological testing.